Citius Oncology logo
Citius Oncology
CTOR | NASDAQ
Chart Builder DCF Calculator
$0.54
-$0.03 (-5.89%)
At close: Nov 16, 2026, 4:00 PM ET
$0.54
-$0.01 (-0.93%)
After-hours: Nov 16, 2026, 4:10 PM ET

Citius Oncology Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Jun 30, 2026
Q2 2026
Mar 31, 2026
Q1 2026
Dec 31, 2025
Q4 2025
Sep 30, 2025
Q3 2025
Jun 30, 2025
Q2 2025
Mar 31, 2025
Q1 2025
Dec 31, 2024
Q4 2024
Sep 30, 2024
Q3 2024
Jun 30, 2024
Q2 2024
Mar 31, 2024
Q1 2024
Dec 31, 2023
Q4 2023
Sep 30, 2023
-8.92M -26.61M -5.53M -5M -5.37M -7.74M -6.66M -22.92M 252.46K 489.83K 1.03M 157.94K
1.72M – 573.44K – – – – – – – – 5.04M
– – – – – – – – – – – –
2.17M 16.58M 574.94K -3.81M 3.93M 4.46M 8.54M 12.79M 17.5K 76.74K 28.66K 297.5K
3.5M 4.97M 3.96M 2.17M 2.06M 2.15M 1.81M 10.17M -634.02K -758.26K -1.28M -5.6M
-109.22K -230.81K 264.24K 272.58K 267.26K 261.01K 264.24K 576K – – – –
960.98K 17.9M -6.61M -2.98M 3.04M 5.32M 4.59M 13.08M 17.5K 76.74K 28.66K 297.5K
-2.85M -3.97M -7.35M -5.53M – – – 900.29K -364.06K -191.69K -218.19K -105.53K
– -5 -4 -5 – – – 0.46 -4.46 – – -4
– – – – – – – – – – – –
– – – – – – – 1.05M -198.53K -200K -653.38K -640.4K
– – – – – – – -25.11M 175.98K 24.94M – –
-2.08M -660.94K -4.4M -5.79M – – – -5M – – – –
-2.08M -660.94K -4.4M -5.79M – – – -29.06M -22.55K 24.74M -653.38K -640.4K
9.83M – – – – – – 3.8M – – – –
– – – – – – – – – – – –
– – – – – – – – – – – –
– – – – – – – 24.39M 353.65K -24.55M 875.08K 411.18K
19.12M -49.67K 15.13M 15.28M – – – 28.19M 353.65K -24.55M 875.08K 411.18K
13.93M -4.66M 3.37M 3.92M – – -32.63K -32.63K -585 585 6.22K -343.57K
-2.85M -3.97M -7.35M -5.53M – – – 900.29K -364.06K -191.69K -218.19K -105.53K
-2.85M -3.97M -7.35M -5.53M – – – 900.29K -364.06K -191.69K -218.19K -105.53K
– – -4 – – – – – – – – -4
– -5 – -5 – – – 0.46 -4.46 – – –
-2.85M -3.97M -7.35M -5.53M – – – 900.29K -364.06K -191.69K -218.19K -105.53K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.